These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12434665)

  • 41. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer.
    Högberg T; Carstensen J; Simonsen E
    Gynecol Oncol; 1993 Jan; 48(1):38-49. PubMed ID: 8423020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic factors of epithelial ovarian cancer in young women].
    Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk factors for recurrent disease in borderline ovarian tumors].
    Líbalová P; Vernerová Z; Hubicková-Heringová L; Pintérová D; Tikovský K; Kubecová M; Svoboda B
    Ceska Gynekol; 2012 Feb; 77(1):31-5. PubMed ID: 22536638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
    Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Granulosa cell tumor--clinical group and literature review].
    Freitag P; Janousek M; Jancárková N; Bendová M; Strunová M; Zivný J
    Ceska Gynekol; 2000 May; 65(3):163-6. PubMed ID: 10953492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors].
    Jancárková N; Krkavcová M; Janashia M; Freitag P; Dusková J; Cibula D
    Ceska Gynekol; 2008 Apr; 73(2):79-86. PubMed ID: 18567425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunotherapy--perspectives in therapy of ovarian carcinomas].
    Zapletalová K; Tobiasová Z; Spísek R; Rob L; Bartůnková J
    Ceska Gynekol; 2004 Sep; 69(5):372-5. PubMed ID: 15587893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ovarian cancers--a solution within reach?].
    Haller U; Lütolf UM; Jungi WF
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1300-5. PubMed ID: 6635629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian carcinoma: a multivariate analysis of prognostic factors.
    Swenerton KD; Hislop TG; Spinelli J; LeRiche JC; Yang N; Boyes DA
    Obstet Gynecol; 1985 Feb; 65(2):264-70. PubMed ID: 3969240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The value of surgical staging in the early stages of ovarian carcinoma].
    Salzer H; Sevelda P; Genger H; Schmidl S; Denison U; Barrada M; Vavra N; Kucera H
    Wien Klin Wochenschr; 1990 Aug; 102(15):437-40. PubMed ID: 2402928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.
    Tomsová M; Melichar B
    Acta Medica (Hradec Kralove); 2006; 49(3):161-5. PubMed ID: 17117604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumors of low malignant potential.
    Leake JF
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):81-5. PubMed ID: 1543834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A survey and study of low potential malignancy of ovarian epithelial tumors].
    Yu HC; Chao KC; Ng HT; Tsai SH; Liu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Apr; 39(4):271-8. PubMed ID: 3455333
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
    Sorbe B; Frankendal B; Veress B
    Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis and treatment of the epithelial ovarian cancer at the West African Cancer Center of Dakar].
    Dem A; Dieng MM; Ka S; Gaye PM; Diouf D; Gaye-Fall MC
    Bull Cancer; 2013 Feb; 100(2):155-60. PubMed ID: 23407147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetic aspects of malignant epithelial ovarian tumours].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2005 Jul; 70(4):299-306. PubMed ID: 16128132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.